A Phase 3, Randomized, Multicenter, Multinational, Double-Blinded Study Comparing the Efficacy and Safety of Repeated Bi-Weekly Infusions ff neoGAA (GZ402666) and Alglucosidase Alfa in Treatment Naive Patients With Late Onset Pompe Disease"

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2016 - June 30, 2021